Tactile Systems Technology, Inc. (TCMD)
NASDAQ: TCMD · Real-Time Price · USD
13.00
-0.30 (-2.26%)
At close: Mar 28, 2025, 4:00 PM
12.78
-0.22 (-1.69%)
After-hours: Mar 28, 2025, 4:31 PM EDT

Company Description

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States.

It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.

The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders.

Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Tactile Systems Technology, Inc.
Tactile Systems Technology logo
Country United States
Founded 1995
IPO Date Jul 28, 2016
Industry Medical Devices
Sector Healthcare
Employees 1,037
CEO Sheri Dodd

Contact Details

Address:
3701 Wayzata Boulevard, Suite 300
Minneapolis, Minnesota 55416
United States
Phone 612 355 5100
Website tactilemedical.com

Stock Details

Ticker Symbol TCMD
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001027838
CUSIP Number 87357P100
ISIN Number US87357P1003
SIC Code 3841

Key Executives

Name Position
Sheri Louise Dodd Chief Executive Officer, President and Director
Elaine M. Birkemeyer Chief Financial Officer
Kristie T. Burns Senior Vice President of Marketing and Clinical Affairs
Daniel L. Reuvers Director and Advisor
Jerry A. Sauber Senior Vice President of Manufacturing, Operations, Research & Development
John David Kaercher Chief Information Officer
Sunday J. Hoy Esq. Vice President of Regulatory Affairs and Chief Compliance Officer
Aaron R. Snodgrass Senior Vice President of Sales
Janelle M. Strop Chief Human Resource Officer
Dr. Antonios P. Gasparis F.A.C.S., M.D. Chief Medical Officer and Member of Vascular Strategic Advisory Board

Latest SEC Filings

Date Type Title
Mar 28, 2025 ARS Filing
Mar 28, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 28, 2025 DEF 14A Other definitive proxy statements
Feb 25, 2025 144 Filing
Feb 25, 2025 144 Filing
Feb 25, 2025 144 Filing
Feb 24, 2025 144 Filing
Feb 24, 2025 144 Filing
Feb 24, 2025 144 Filing
Feb 24, 2025 144 Filing